COSCIENS BIOPHARMA INC (CSCI) Stock Cash Flow
NASDAQ:CSCI - Nasdaq - CA22112H1010 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.21M | -16.55M | -22.73M | -8.37M | -5.12M | |||
| Depreciation Amortization | 1.25M | 169.00K | 140.00K | 150.00K | 230.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -2.85M | 293.00K | 1.44M | 900.00K | 950.00K | |||
| Taxes Paid | N/A | -1.33M | -830.00K | 1.61M | 1.45M | |||
| Other non cash items | -1.16M | -1.03M | 7.48M | -1.25M | -200.00K | |||
| OPERATING CASH FLOW | -16.95M | -17.12M | -13.68M | -8.58M | -4.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -861.00K | -19.00K | -10.00K | -640.00K | N/A | |||
| Other Investing Activity | N/A | 547.00K | 0.00 | -20.00K | 60.00K | |||
| INVESTING CASH FLOW | 25.95M | 528.00K | -10.00K | -660.00K | 60.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -353.00K | -151.00K | -130.00K | -130.00K | -270.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 0.00 | 54.29M | 23.50M | |||
| Other Financing Activity | N/A | 0.00 | 20.00K | -3.12M | -2.77M | |||
| FINANCING CASH FLOW | -427.00K | -151.00K | -120.00K | 51.04M | 20.47M | |||
| Exchange Rate Effect | 12.00K | 146.00K | -880.00K | -770.00K | 40.00K | |||
| CHANGE IN CASH | 8.59M | -16.59M | -14.69M | 41.03M | 16.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.95M | -17.12M | -13.68M | -8.58M | -4.13M | |||
| Capital Expenditure | -861.00K | -19.00K | -10.00K | -640.00K | N/A | |||
| FREE CASH FLOW | -17.81M | -17.14M | -13.69M | -9.22M | -4.13M | |||
All data in USD